Cytidine deaminases catalyze the conversion of <i>N</i>(<i>S</i>,<i>O</i>)<sup>4</sup>-substituted pyrimidine nucleosides.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36735785.
- Also identified by DOI 10.1126/sciadv.ade4361 and PMC identifier 9897663.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Cytidine deaminases (CDAs) catalyze the hydrolytic deamination of cytidine and 2'-deoxycytidine to uridine and 2'-deoxyuridine. Here, we report that prokaryotic homo-tetrameric CDAs catalyze the nucleophilic substitution at the fourth position of <i>N</i><sup>4</sup>-acyl-cytidines, <i>N</i><sup>4</sup>-alkyl-cytidines, and <i>N</i><sup>4</sup>-alkyloxycarbonyl-cytidines, and <i>S</i><sup>4</sup>-alkylthio-uridines and <i>O</i><sup>4</sup>-alkyl-uridines, converting them to uridine and corresponding amide, amine, carbamate, thiol, or alcohol as leaving groups. The x-ray structure of a metagenomic CDA_F14 and the molecular modeling of the CDAs used in this study show a relationship between the bulkiness of a leaving group and the volume of the binding pocket, which is partly determined by the flexible β3α3 loop of CDAs. We propose that CDAs that are active toward a wide range of substrates participate in salvage and/or catabolism of variously modified pyrimidine nucleosides. This identified promiscuity of CDAs expands the knowledge about the cellular turnover of cytidine derivatives, including the pharmacokinetics of pyrimidine-based prodrugs.
Medical subject headings
- Pyrimidine Nucleosides